सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Centre proposes 30% trade-margin cap on cancer drugs to save ₹2,500 crore annually

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·

Pharmaceutical price regulation and public health affordability: a GS2 Social Justice and GS3 Economics case study.

Why in news

The Centre proposed a 30% trade-margin cap on non-scheduled cancer drugs to the Supreme Court to reduce annual costs by ₹2,500 crore.

Background

The Supreme Court heard petitions by Kishan Chand Jain and Sanjay Kulshrestha regarding pharmaceutical price controls. The Centre's proposal aims to cap trade margins for non-scheduled cancer drugs to achieve an annual saving of ₹2,500 crore.

Facts for Prelims

  • FactProposed trade-margin cap: 30% for non-scheduled cancer drugs
  • FactProjected annual savings: ₹2,500 crore
  • PlaceSupreme Court: Venue of the hearing on pharmaceutical price controls

Prelims practice question

With reference to the Centre's proposal on cancer drug pricing, consider the following statements:

  1. The proposed trade-margin cap for non-scheduled cancer drugs is 30%.
  2. The proposal seeks to cap trade margins for all scheduled cancer drugs.
  3. The proposal aims to achieve an annual saving of ₹2,500 crore.

Which of the statements given above is/are correct?

  1. (a)2 only
  2. (b)3 only
  3. (c)1 and 3 only
  4. (d)1, 2 and 3
Show answer

Answer: (c) 1 and 3 only — Statements 1 and 3 are correct. Statement 2 is incorrect: The proposal specifically targets non-scheduled cancer drugs.

For Mains

Q. Discuss the balance between ensuring the affordability of life-saving medicines and maintaining the viability of the pharmaceutical manufacturing sector in India.

Dimensions to cover in your answer

  • Market distortion: Potential impact of trade-margin caps on R&D investment for non-scheduled drugs
  • Regulatory scope: Conflict between price control for essential medicines vs. broader medical device regulation
  • Public health equity: Balancing the right to affordable healthcare with private sector profit margins

Keywords: Price Control · Pharmaceutical Regulation · Affordability · Trade Margin · Public Health Policy

Read the full news →Report a mistake in this noteHow notes are madeSource: The Hindu ↗Also: GS3 · Industry, investment & MSMEs

More Social Justice notes

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.